Efforts were made to demonstrate that in biorefineries it is possible to manufacture all the commodities required for maintaining human civilisation on the current level. Biorefineries are based on processing biomass resulting from photosynthesis. From sugars, oils and proteins, a variety of food, feed, nutrients, pharmaceuticals, polymers, chemicals and fuels can further be produced. Production in biorefineries must be based on a few rules to fulfil sustainable development: all raw materials are derived from biomass, all products are biodegradable and production methods are in accordance with the principles of Green Chemistry and Clean Technology. The paper presents a summary of state-of-the-art concerning biorefineries, production methods and product range of leading companies in the world that are already implemented. Potential risks caused by the development of biorefineries, such as: insecurities of food and feed production, uncontrolled changes in global production profiles, monocultures, eutrophication, etc., were also highlighted in this paper. It was stressed that the sustainable development is not only an alternative point of view but is our condition to survive.

Due to the increased environmental awareness, green chemistry becomes an important element of environmental protection. Unfortunately, it generate specific environmental costs, which are related to the use of toxic chemical reagents and waste generation. The most frequently determined analytes include inorganic and organic anions and cations. The methods used so far for their analysis in water, sewage and various other types of samples are increasingly being replaced by ion chromatography methods. This paper presents the most important advantages and limitations of ion chromatography in the context of “green analytical chemistry.” The progress of ion chromatography in gradient and isocratic elution, capillary and multidimensional ion chromatography, as well as miniaturization and methods of sample preparation for analysis, which allow to classify this technique as green analytical chemistry, are described

Correct diagnosis and appropriate selection of pharmacotherapy will not upgrade patient’s health if the drug is not available in the pharmacy. Pharmaceutical supply chain breakdown may occur due to epidemiological or political reasons. Then, the finished drug form factories located in Poland will not secure the drug supply. Thus, cooperation of the scientific community with the pharmaceutical and chemical industries is necessary to boost the domestic manufacturing of active pharmaceutical substances and substrates. Due to number of substances needed, the scale of national demand and the investments, the problem needs to be solved at European level. The Pharmaceutical Strategy for Europe is an important guidance in this regard. The aim of our paper is to review the current state, indicate solutions and initiate a discussion on the development of the synthesis of active pharmaceutical substances in Poland. We focused on small-molecular compounds, the national perspective and the relationship between the synthesis of active substances and protection of the natural environment. Point actions for investments in infrastructure as well as research and development are not enough. Thus, we propose to create a system supporting synthesis of active pharmaceutical substances in Poland.